Financial
Part of Agfa-Gevaert (AGFB.BR).
Latest full-year results not yet captured by HSH.
HQ Belgium · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Part of Agfa-Gevaert (AGFB.BR).
Latest full-year results not yet captured by HSH.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products not yet catalogued.
Part of Agfa-Gevaert (AGFB.BR).
Latest full-year results not yet captured by HSH.
No adverse media involving Agfa HealthCare found in HSH's search of the last 24 months.
No data breaches, cyber incidents or regulator action involving Agfa HealthCare found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Nov 2025: AGFA Healthcare Corp began an FDA Class 2 recall of 35 US DR 800 X-ray systems, which could exceed the maximum allowed air kerma rate during pulsed fluoroscopy in certain settings; a generator software update was to be installed.
May 2026: Agfa HealthCare reported multiple Enterprise Imaging go-lives in North America in Q1 2026, without naming customers. May 2025: Queen Elizabeth Hospital King's Lynn NHS FT renewed Agfa Enterprise Imaging maintenance for a year.
No competitors linked yet.